End-of-day quote
Korea S.E.
06:00:00 2024-06-13 pm EDT
5-day change
1st Jan Change
7,680
KRW
0.00%
+1.32%
-18.38%
Ahn-Gook Pharmaceutical Co., Ltd.'s Equity Buyback announced on March 27, 2020 has expired with 93,781 shares, representing 0.82% for KRW 989.14 million.
The company expired its plan on September 23, 2022.
Ahn-Gook Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
May. 16
CI
Ahn-Gook Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
Mar. 20
CI
Ahn-Gook Pharmaceutical Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
Nov. 14
CI
Ahn-Gook Pharmaceutical Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
23-08-11
CI
Ahn-Gook Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
23-05-15
CI
Ahn-Gook Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
23-03-22
CI
Ahn-Gook Pharmaceutical Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
22-11-14
CI
Tranche Update on Ahn-Gook Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on March 27, 2020.
22-09-22
CI
Tranche Update on Ahn-Gook Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on March 27, 2020.
22-09-22
CI
Tranche Update on Ahn-Gook Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on March 27, 2020.
22-09-22
CI
Tranche Update on Ahn-Gook Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on March 27, 2020.
22-09-22
CI
Tranche Update on Ahn-Gook Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on March 27, 2020.
22-09-22
CI
Ahn-Gook Pharmaceutical Co., Ltd.'s Equity Buyback announced on March 27, 2020 has expired with 93,781 shares, representing 0.82% for KRW 989.14 million.
22-09-22
CI
Tranche Update on Ahn-Gook Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on December 26, 2002.
22-06-24
CI
Ahn-Gook Pharmaceutical Co., Ltd.'s Equity Buyback announced on December 26, 2002, has expired with 1,145,246 shares, representing 97.65% for KRW 2,441.63 million.
22-06-23
CI
Ahn-Gook Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022
22-05-16
CI
Ahn-Gook Pharmaceutical Co., Ltd.'s Equity Buyback Plan Extended till September 23, 2022.
22-03-24
CI
Ahn-Gook Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021
22-03-21
CI
Ahn-Gook Pharmaceutical Co., Ltd.'s Equity Buyback announced on January 8, 2021, has expired.
22-01-06
CI
Ahn-Gook Pharmaceutical Co. Ltd.'s Equity Buyback Plan Extended till June 24, 2022.
21-12-23
CI
Ahn-Gook Pharmaceutical Co., Ltd.'s Equity Buyback announced on December 26, 2002, has expired.
21-12-23
CI
Ahn-Gook Pharmaceutical Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021
21-11-15
CI
Ahn-Gook Pharmaceutical Co., Ltd.'s Equity Buyback announced on March 27, 2020, has expired.
21-09-24
CI
Ahn-Gook Pharmaceutical Co. Ltd.'s Equity Buyback Plan Extended till June 24, 2021.
21-06-23
CI
Ahn-Gook Pharmaceutical Co., Ltd.'s Equity Buyback Plan Extended till September 25, 2021.
21-03-24
CI
Duration Auto. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max.
Period Day Week
More charts
AHN-GOOK PHARMACEUTICAL Co., Ltd. is a Korea-based company engaged in the manufacture of pharmaceuticals. The Companyâs products include respiratory agents, gastrointestinal agents, anti-inflammatory, analgesic agents, ophthalmic agents and circulatory system agents. It also provides antibiotic, antifungal drugs, antihyperlipidemic agents, antiallergic drugs, anti-diabetic drugs, urinary system drugs and skin disease remedies. In addition, the Company provides other over the counter (OTC) and ethical (ETC) drugs. The Company distributes its product within domestic market and to overseas markets.
More about the company
1st Jan change
Capi.
-18.38% 63.07M +20.37% 43.54B +19.44% 21.78B +17.85% 15.38B +25.55% 15.12B +60.99% 13.36B -0.05% 6.79B -15.02% 6.38B -8.87% 5.73B +8.17% 5.32B
Generic Pharmaceuticals
+951% of historical performance
More than 20 years at your side
Our Experts are here for you
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1